ArticleDiscover oncology2025
Exploring the genetic determinants of the oral microbiome's role in gastrointestinal cancer risk: Mendelian randomization and genetic correlation analysis in an East Asian population.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Two-Sample Mendelian Randomisation Analysis of the Oral Microbiome and Oral/Oropharyngeal/Tongue Cancers.Oral health & preventive dentistry · 2026Article
- Potential value of oral Mogibacterium in major depressive disorder.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe human oral microbiome plays a significant role in systemic health, including potential links to digestive tract cancers. However, few studies have examined the causal relationship between the oral microbiota and digestive tract cancers using robust methodologies. This study aimed to investigate the causal associations between specific oral microbiota and the risk of gastric, esophageal, colorectal, liver, and pancreatic cancers using a Mendelian randomization (MR) approach.
methodsWe employed a two-sample MR analysis using genome-wide association study (GWAS) data from 2,948 individuals from the CNGBdb for the oral microbiome and over 150,000 individuals from BioBank Japan for digestive cancers. Single nucleotide polymorphisms (SNPs) associated with the oral microbiota were selected as instrumental variables, and the inverse-variance weighted (IVW) method was used for causal estimates. Sensitivity analyses, including MR‒Egger regression and leave-one-out tests, were performed to assess pleiotropy and robustness. Linkage disequilibrium score regression (LDSC) was applied to explore genetic correlations.
resultsOur MR analysis revealed several suggestive associations between the oral microbiota and digestive tract cancers. For esophageal cancer, both Fusobacterium periodonticum (OR = 1.36, 95% CI 0.16-1.59, P < 0.001) and Fusobacterium massiliense (OR = 1.31, 95% CI 0.10-1.56, P = 0.003) were positively associated with increased risk, whereas Streptococcus (OR = 0.75, 95% CI 0.64-0.89, P < 0.001) and TM7x (OR = 0.77, 95% CI 0.63-0.94, P = 0.011) exhibited protective effects. For gastric cancer, Veillonella rogosae was significantly associated with increased risk (OR = 1.14, 95% CI 01.7-1.22, P < 0.001), whereas Haemophilus_D (OR = 0.86, 95% CI 0.78-0.95, P = 0.003) had a protective effect. For colorectal cancer, MR analysis combined with LDSC analysis revealed that Campylobacter_A_concisus_D_mgs_2798 (OR = 0.92, 95% CI 0.85-0.99, P = 0.028), Campylobacter_A_concisus_F_mgs_1384 (OR = 0.91, 95% CI 0.85-0.99, P = 0.019), and Stomatobaculum (OR = 0.90, 95% CI 0.83-0.98, P = 0.017) exhibited protective effects. In hepatic cancer, according to the MR and LDSC results, Leptotrichia was correlated with hepatic cancer, with an OR of 1.18 (95% CI 1.01-1.38, P = 0.032). For pancreatic cancer, Mogibacterium was associated with an increased risk (OR = 1.55, 95% CI 1.16-2.06, P = 0.003), and Pauljensenia had a protective effect (OR = 0.53, 95% CI 0.40-0.70, P < 0.001).
conclusionThis study provides novel insights into the causal role of specific oral bacteria in the development of digestive tract cancers. These findings highlight potential microbial targets for cancer prevention and intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.